VITA THERAPEUTICS RAISES $32 MILLION
Vita Therapeutics Raises $32 Million in Oversubscribed Series A Financing Led by Cambrian Biopharma to Advance the Development of Therapies to Treat Muscular Dystrophies BALTIMORE, Md. – Jun. 23, 2021 –Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop cellular
LEARN MORE